Latest news with #JulieVanOngevalle
Zawya
02-07-2025
- Business
- Zawya
Egypt: Opella becomes first global consumer healthcare firm to gain B Corp status
Egypt - Opella has become the first global consumer healthcare company to achieve B Corp Certification after meeting the social and environmental standards set by B Lab, the non-profit organisation behind the accreditation. The certification covers Opella's global operations and follows a four-year transformation process, during which the company said it redefined its approach to sustainability, innovation and governance. The company demonstrated strong performance in areas including climate action, product sustainability, community health and leadership accountability. 'Being B Corp certified globally is a first step on our sustainability journey,' Julie Van Ongevalle, Opella President and CEO, said in a statement. 'We owe it to the incredible work done by our 11,000 employees across the globe, our customers and our consumers. It is a commitment to redefine self-care by proving that business success and sustainability can and must go hand in hand.' The company cited several achievements on its path to certification, including a 64% reduction in its Scope 1 and 2 greenhouse gas emissions since 2019 and sourcing over 93% of its electricity from renewable sources. As of 2024, 97% of Opella's paper-based packaging comes from certified or recycled materials. Opella also reported that its partnerships with local non-governmental organisations on community programmes have directly benefited over one million people since 2022. In 2024 alone, its educational campaigns on health awareness and responsible medicine use reached over 129 million individuals. 'This recognition reflects the ambition that drives us forward,' said Marissa Saretsky, Chief Sustainability Officer. 'Going through the certifying process has been an amazing catalyst to drive our sustainability transformation, spur innovation, and engage our employees. It sets a global benchmark, and we are committed to leading from the front by turning high standards into everyday action. This is just the beginning.' Feirouz Ellouze, General Manager for Opella in Africa, the Middle East and Turkiye, added that the certification marks the beginning of a deeper commitment. 'B Corp certification marks the beginning of our journey to deepen our commitment to environmental stewardship,' Ellouze said. 'At Opella, we believe that our mission to bring health into the hands of our consumers is inseparable from our responsibility to care for the planet. Sustainability isn't a side initiative—it's a core part of who we are and what we do. We can't deliver health without honoring the planet—because true well-being begins with a thriving world.'
Daily News Egypt
01-07-2025
- Business
- Daily News Egypt
Opella becomes first global consumer healthcare firm to gain B Corp status
Opella has become the first global consumer healthcare company to achieve B Corp Certification after meeting the social and environmental standards set by B Lab, the non-profit organisation behind the accreditation. The certification covers Opella's global operations and follows a four-year transformation process, during which the company said it redefined its approach to sustainability, innovation and governance. The company demonstrated strong performance in areas including climate action, product sustainability, community health and leadership accountability. 'Being B Corp certified globally is a first step on our sustainability journey,' Julie Van Ongevalle, Opella President and CEO, said in a statement. 'We owe it to the incredible work done by our 11,000 employees across the globe, our customers and our consumers. It is a commitment to redefine self-care by proving that business success and sustainability can and must go hand in hand.' The company cited several achievements on its path to certification, including a 64% reduction in its Scope 1 and 2 greenhouse gas emissions since 2019 and sourcing over 93% of its electricity from renewable sources. As of 2024, 97% of Opella's paper-based packaging comes from certified or recycled materials. Opella also reported that its partnerships with local non-governmental organisations on community programmes have directly benefited over one million people since 2022. In 2024 alone, its educational campaigns on health awareness and responsible medicine use reached over 129 million individuals. 'This recognition reflects the ambition that drives us forward,' said Marissa Saretsky, Chief Sustainability Officer. 'Going through the certifying process has been an amazing catalyst to drive our sustainability transformation, spur innovation, and engage our employees. It sets a global benchmark, and we are committed to leading from the front by turning high standards into everyday action. This is just the beginning.' Feirouz Ellouze, General Manager for Opella in Africa, the Middle East and Turkiye, added that the certification marks the beginning of a deeper commitment. 'B Corp certification marks the beginning of our journey to deepen our commitment to environmental stewardship,' Ellouze said. 'At Opella, we believe that our mission to bring health into the hands of our consumers is inseparable from our responsibility to care for the planet. Sustainability isn't a side initiative—it's a core part of who we are and what we do. We can't deliver health without honoring the planet—because true well-being begins with a thriving world.'
Zawya
01-07-2025
- Business
- Zawya
Opella achieves global B Corp Certification
Egypt – Opella is the first global consumer healthcare company to achieve B Corp Certification, after meeting the rigorous social and environmental standards set by B Lab, the nonprofit behind the certification. This achievement marks a milestone on Opella's journey to deliver responsible self-care for people and planet. This certification follows an intensive four-year transformation effort, during which Opella has redefined its approach to sustainability, innovation, and governance in all countries across its global operations. The company demonstrated strong performance in key areas including climate action, product sustainability, community health, and accountability at leadership level. Julie Van Ongevalle, Opella President and CEO: ' Being B Corp certified globally is a first step on our sustainability journey. We owe it to the incredible work done by our 11,000 employees across the globe, our customers and our consumers. It is a commitment to redefine self-care by proving that business success and sustainability can and must go hand in hand. ' Marissa Saretsky, Chief Sustainability Officer: ' This recognition reflects the ambition that drives us forward. Going through the certifying process has been an amazing catalyst to drive our sustainability transformation, spur innovation, and engage our employees. It sets a global benchmark, and we are committed to leading from the front by turning high standards into everyday action. This is just the beginning. ' Feirouz Ellouze, Opella Africa,Middle East, Turkiye (AMET) General Manager: " B Corp certification marks the beginning of our journey to deepen our commitment to environmental stewardship. At Opella, we believe that our mission to bring health into the hands of our consumers is inseparable from our responsibility to care for the planet. Sustainability isn't a side initiative—it's a core part of who we are and what we do. We can't deliver health without honoring the planet—because true well-being begins with a thriving world." Key achievements include a 64% reduction in Scope 1 and 2 greenhouse gas emissions since 2019 and sourcing over 93% of Opella's electricity from renewable sources. As of 2024, 97% of Opella's paper-based packaging comes from certified or recycled materials. Additionally, since 2022, Opella's partnership with local NGOs on community programs has directly benefited over 1 million people, and in 2024 alone, its educational campaigns on health awareness and responsible use of medicine reached over 129 million individuals. Opella joins a community of committed companies and encourages more self-care players to join the journey toward greater responsibility and impact. Looking ahead, Opella views B Corp certification as a dynamic framework for continued progress. Its commitment to recertify regularly ensures the company remains focused on advancing innovative, inclusive, and measurable solutions for a healthy society and planet. About B Lab: B Lab is a nonprofit transforming the global economy to benefit all people, communities, and the planet. A leader in economic systems change, our global network creates standards, policies, tools, and programs for business, and we certify companies, known as B Corps, who are leading the way. To date, our community includes 950,000 workers in over 9,600 B Corps across 102 countries and 161 industries. About Opella. Opella is the self-care challenger with third-largest portfolio in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market globally. Our mission is to bring health in people's hands by making self-care as simple as it should be. For half a billion consumers worldwide – and counting. At the core of this mission are our brands worldwide, our 11,000-strong global team, our 13 best-in-class manufacturing sites and 4 specialized science and innovation development centers. Headquartered in France, Opella is the proud maker of many brands worldwide, including Telfast, Doliprane, Bronchicum, Enterogermina, Maalox, Nasacort, Maxilase, Bisolvon and Buscopan, B Corp certified, we are active players in the journey towards healthier people and planet.
Tahya Masr
06-05-2025
- Business
- Tahya Masr
Opella launches as an independent company to redefine the future of self-care
It is official: Opella is now a standalone company. Sanofi announced today the closing of the sale to CD&R of a 50.0% controlling stake of Opella, Sanofi keeping a significant shareholding with a 48.2% stake and Bpifrance owning a 1.8% stake. Opella is stepping into its next chapter with powerful backing, and a clear mission - 'Health in Your Hands' - making self-care as simple as it should be. This is not just a change of ownership. This is a bold move. As the third-largest global player in the €190 billion Over-The-Counter and Vitamins, Minerals and Supplements space, Opella starts a new journey in one of the most dynamic, resilient corners of healthcare – where megatrends like aging populations, digital access, and self-care demand are rewriting the rulebook. Opella is headquartered in France but thinks global. Its 100 brands – including Telfast, Doliprane, Bronchicum, Enterogermina, Maalox, Nasacort, Maxilase, Bisolvon and Buscopan – are already trusted names in homes around the world. The self-care environment is still far too complex, leaving most people who suffer without treatment. Opella is grounded in science, with deep consumer obsession and a commitment to sustainability, to offer solutions that help people access the care they deserve. Julie Van Ongevalle, Opella President and CEO: 'Going independent is not just a milestone. It is our moment. I am proud of our talented team of 11,000 who made this happen. With the right partners and a sharp focus, we are set to reshape how people everywhere manage their health – simply, confidently, and on their terms.' Feirouz Ellouze, General Manager of Opella AMET Zone (Africa-Middle East-Türkiye) 'At Opella, our mission is to simplify self-care, making it as simple as it should be. We work together with all our stakeholders to enhance health literacy and extend our vision of 'health in your hands'. This new chapter at Opella is dedicated to advancing our journey towards becoming fast-moving consumer healthcare company globally. We firmly believe in our people and their ability to create a lasting legacy in the countries where we operate.' David Taylor takes on the role of Chairman of Opella's Supervisory Board. Former Chairman and CEO of Procter & Gamble, and current Chairman of the Board of Delta and Senior Advisor to CD&R funds, David brings decades of brand experience, people-first leadership, and a deep belief in doing things better. David Taylor, Chairman of Opella's Supervisory Board: 'What drew me to Opella is a mission with meaning, a company with courage, a talented team, and a business ready to break new ground. Opella is not here to tweak the system – but to reimagine it.' The priority is clear: strengthen trusted brands and deepen presence in key markets. The possibilities are endless – from prescription to over-the-counter switches to smart acquisitions and geographic expansion. This is more than independence. It is the freedom to act. The power to simplify. And the drive to redefine the future of self-care.
Mid East Info
05-05-2025
- Business
- Mid East Info
Opella launches as an independent company to redefine the future of self-care. - Middle East Business News and Information
UAE, May 2025 – It is official: Opella is now a standalone company. Sanofi announced today the closing of the sale to CD&R of a 50.0% controlling stake of Opella, Sanofi keeping a significant shareholding with a 48.2% stake and Bpifrance owning a 1.8% stake. Opella is stepping into its next chapter with powerful backing, and a clear mission – 'Health in Your Hands' – making self-care as simple as it should be. This is not just a change of ownership. This is a bold move. As the third-largest global player in the €190 billion Over-The-Counter and Vitamins, Minerals and Supplements space, Opella starts a new journey in one of the most dynamic, resilient corners of healthcare – where megatrends like aging populations, digital access, and self-care demand are rewriting the rulebook. Opella is headquartered in France but thinks global. Its 100 brands – including Telfast , Enterogermina, Dulcolax, Maalox, Buscopan ,Mucosolvan , Bronchicum ,Naselfast and Pharmaton– are already trusted names in homes around the world. The self-care environment is still far too complex, leaving most people who suffer without treatment. Opella is grounded in science, with deep consumer obsession and a commitment to sustainability, to offer solutions that help people access the care they deserve. Julie Van Ongevalle, Opella President and CEO: 'Going independent is not just a milestone. It is our moment. I am proud of our talented team of 11,000 who made this happen. With the right partners and a sharp focus, we are set to reshape how people everywhere manage their health – simply, confidently, and on their terms.' Feirouz Ellouze, General Manager of Opella AMET Zone (Africa-Middle East-Türkiye) 'At Opella, our mission is to simplify self-care, making it as simple as it should be. We work together with all our stakeholders to enhance health literacy and extend our vision of 'health in your hands'. This new chapter at Opella is dedicated to advancing our journey towards becoming fast-moving consumer healthcare company globally. We firmly believe in our people and their ability to create a lasting legacy in the countries where we operate.' David Taylor takes on the role of Chairman of Opella's Supervisory Board. Former Chairman and CEO of Procter & Gamble, and current Chairman of the Board of Delta and Senior Advisor to CD&R funds, David brings decades of brand experience, people-first leadership, and a deep belief in doing things better. David Taylor, Chairman of Opella's Supervisory Board: 'What drew me to Opella is a mission with meaning, a company with courage, a talented team, and a business ready to break new ground. Opella is not here to tweak the system – but to reimagine it.' The priority is clear: strengthen trusted brands and deepen presence in key markets. The possibilities are endless – from prescription to over-the-counter switches to smart acquisitions and geographic expansion. This is more than independence. It is the freedom to act. The power to simplify. And the drive to redefine the future of self-care. About Opella. Opella is the self-care challenger with the third-largest portfolio in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market globally. Our mission is to bring health in people's hands by making self-care as simple as it should be. For half a billion consumers worldwide – and counting. At the core of this mission is our 100 loved brands, our 11,000-strong global team, our 13 best-in-class manufacturing sites and 4 specialized science and innovation development centers. Headquartered in France, Opella is the proud maker of many of the world's most loved brands, including Telfast , Enterogermina, Dulcolax, Maalox, Buscopan ,Mucosolvan , Bronchicum ,Naselfast, Pharmaton. B Corp certified in multiple markets, we are active players in the journey towards healthier people and planet.
